Genomics of Immunotherapy-Associated Hyperprogressors-Letter.

Forschner, Andrea; Niessner, Heike; Möller, Yvonne; Horak, Peter; Fröhlich, Martina; Warsow, Gregor; Stenzinger, Albrecht; Fröhling, Stefan; Glimm, Hanno; Klumpp, Bernhard; Garbe, Claus; Sinnberg, Tobias

Forschner, Andrea; Niessner, Heike; Möller, Yvonne; Horak, Peter; Fröhlich, Martina; Warsow, Gregor; Stenzinger, Albrecht; Fröhling, Stefan; Glimm, Hanno; Klumpp, Bernhard; Garbe, Claus; Sinnberg, Tobias.

Afiliación

Forschner A; Department of Dermatology, University Hospital, Tuebingen, Germany. andrea.forschner@med.uni-tuebingen.de.
Niessner H; Department of Dermatology, University Hospital, Tuebingen, Germany.
Möller Y; Center for Personalised Medicine, University Hospital, Tuebingen, Germany.
Horak P; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
Fröhlich M; German Cancer Consortium (DKTK), Heidelberg, Germany.
Warsow G; Division Applied Bioinformatics, DKFZ and NCT, Heidelberg, Germany.
Stenzinger A; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fröhling S; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Glimm H; German Cancer Consortium (DKTK), Heidelberg, Germany.
Klumpp B; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
Garbe C; German Cancer Consortium (DKTK), Heidelberg, Germany.
Sinnberg T; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.

Clin Cancer Res ; 23(20): 6374-6375, 2017 10 15.

Article en En | MEDLINE | ID: mdl-29030332

Asunto(s)

Factores Inmunológicos; Inmunoterapia; Genómica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores Inmunológicos / Inmunoterapia Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google